Patents by Inventor Anders Malmstrom

Anders Malmstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7531338
    Abstract: 3-OST-5 proteins, and nucleic acid molecules encoding the same. Recombinant host cells, recombinant nucleic acids and recombinant proteins are also disclosed, along with methods of producing each. Isolated and purified antibodies to 3-OST-5 homologs, and methods of producing the same, are also disclosed. 3OST-5 gene products have biological activity in specific heparan sulfate 3-O-sulfotransferase reactions. These reactions provide unique modified heparan sulfate. Thus, therapeutic methods involving this activity are also disclosed.
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: May 12, 2009
    Assignees: The University of North Carolina at Chapel Hill, The Board of Trustees of the University of Illinois
    Inventors: Jian Liu, Guoqing Xia, Jinghua Chen, Michael B. Duncan, Deepak Shukla, Vaibhav Tiwari, Anders Malmstrom
  • Publication number: 20080269165
    Abstract: The invention refers to the use of sulfated glycosamino-glycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in women.
    Type: Application
    Filed: July 7, 2008
    Publication date: October 30, 2008
    Inventors: Gunvor EKMAN-ORDEBERG, Anders Malmstrom
  • Publication number: 20060165673
    Abstract: 3-OST-5 proteins, and nucleic acid molecules encoding the same. Recombinant host cells, recombinant nucleic acids and recombinant proteins are also disclosed, along with methods of producing each. Isolated and purified antibodies to 3-OST-5 homologs, and methods of producing the same, are also disclosed. 3OST-5 gene products have biological activity in specific heparan sulfate 3-O-sulfotransferase reactions. These reactions provide unique modified heparan sulfate. Thus, therapeutic methods involving this activity are also disclosed.
    Type: Application
    Filed: July 7, 2003
    Publication date: July 27, 2006
    Inventors: Jian Liu, Guoqing Xia, Jinghua Chen, Michael Duncan, Deepark Shuka, Vaibhav Tiwari, Anders Malmstrom
  • Publication number: 20050075314
    Abstract: The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic priming or curative treatment of the cervix and the myometrium for establishing effective labor in women.
    Type: Application
    Filed: January 2, 2003
    Publication date: April 7, 2005
    Inventors: Gunvor Ekman-Ordeberg, Anders Malmstrom